Immunological control of Epstein-Barr virus-transformed lymphocytes in multiple sclerosis
- 1 October 1983
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 29 (1), 86-93
- https://doi.org/10.1016/0090-1229(83)90009-0
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- DEFICIT OF SUPPRESSOR T CELLS IN ACTIVE MULTIPLE SCLEROSISThe Lancet, 1980
- Defective immunoreguktion in multiple sclerosisAnnals of Neurology, 1980
- Loss of Suppressor T Cells in Active Multiple SclerosisNew England Journal of Medicine, 1980
- INCREASED TENDENCY TO SPONTANEOUS IN-VITRO LYMPHOCYTE TRANSFORMATION IN CLINICALLY ACTIVE MULTIPLE SCLEROSISThe Lancet, 1979
- In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects.The Journal of Experimental Medicine, 1978
- Assay of the Infectivity of Epstein-Barr Virus by Transformation of Human Leucocytes in vitroJournal of General Virology, 1972
- Antibody levels to parainfluenza, herpes simplex, varicella-zoster, cytomegalo virus, and measles virus in patients with connective tissue diseases.Annals Of The Rheumatic Diseases, 1972
- VIRUS ANTIBODY LEVELS IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUSActa Medica Scandinavica, 1972
- Clinically Evident, Non-terminal Infections with Herpesviruses and the Wart Virus in Immunosuppressed Renal Allograft RecipientsBMJ, 1970
- HERPES-SIMPLEX-VIRUS INFECTION AFTER RENAL TRANSPLANTATIONThe Lancet, 1969